OpenAI’s Specialized Rosalind Model Poised to Revolutionize Pharma’s 15-Year Drug Pipeline

OpenAI’s GPT-Rosalind could slash pharma’s brutal 15-year drug pipeline using protein reasoning and genomics. But can AI truly replace wet-lab science?

FDA Reveals Game-Changing Framework for AI in Pharmaceutical Development

FDA drops bombshell AI framework that could revolutionize drug development forever – but pharmaceutical giants might hate what comes next.

Beyond Human Limits: How AI Is Slashing Drug Development From 15 Years to 18 Months

AI slashes drug development from 15 years to 18 months, challenging medical dogma. Faster treatments and lower costs are revolutionizing healthcare. What does this mean for untreatable diseases?